A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD

Clinical trial NCT01436864 · COMPLETED

Trial details

NCT number: NCT01436864
Sponsor: Chengdu Kanghong Biotech Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration

Start date: 2011-08-01
Primary completion: 2012-12-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.